Insider · CIK 0001310880

Hung David

Reports to the SEC for 7 companies · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001310880

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-03	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	16,999
2026-06-03	NVCRNovoCure LtdA Award	Director	AAward	+11.6K sh	—	—	32,075
2026-06-02	NVCRNovoCure LtdS Sale	Director	SSale	−2,945 sh	$15.77	−$46.4K	20,465
2026-02-27	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+2M sh	—	—	1,995,012
2025-06-16	NUVBNuvation Bio Inc.P Purchase	Director, PRESIDENT AND CEO, 10% Owner	PPurchase	+500K sh	$1.79	+$894K	59,281,054
2025-06-04	NVCRNovoCure LtdA Award	Director	AAward	+11.2K sh	—	—	23,410
2025-06-04	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,697
2025-06-03	NVCRNovoCure LtdS Sale	Director	SSale	−999 sh	$17.30	−$17.3K	12,195
2025-04-07	NUVBNuvation Bio Inc.P Purchase	Director, PRESIDENT AND CEO, 10% Owner	PPurchase	+300K sh	$1.63	+$488K	58,781,054
2025-04-04	NUVBNuvation Bio Inc.P Purchase	Director, PRESIDENT AND CEO, 10% Owner	PPurchase	+200K sh	$1.66	+$333K	58,481,054
2025-02-28	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+2M sh	—	—	2,000,000
2024-06-05	NVCRNovoCure LtdA Award	Director	AAward	+4,053 sh	—	—	13,194
2024-06-05	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+6,229 sh	—	—	6,229
2024-02-29	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+2M sh	—	—	2,000,000
2023-06-07	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+12.6K sh	—	—	12,554
2023-02-28	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+2.5M sh	—	—	2,500,000
2022-06-08	NVCRNovoCure LtdA Award	Director	AAward	+2,427 sh	—	—	9,141
2022-06-08	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+4,350 sh	—	—	4,350
2022-02-28	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+2M sh	—	—	2,000,000
2021-06-09	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+1,499 sh	—	—	1,499
2021-06-09	NVCRNovoCure LtdA Award	Director	AAward	+814 sh	—	—	6,714
2021-03-09	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+225K sh	—	—	224,760
2021-03-09	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+165K sh	—	—	165,465
2021-03-02	NUVBNuvation Bio Inc.J Other	Director, PRESIDENT AND CEO, 10% Owner	JOther	−368K sh	—	—	58,281,054
2021-02-10	NUVBNuvation Bio Inc. · Class B Common StockA Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+1M sh	—	—	1,000,000
2021-02-10	NUVBNuvation Bio Inc.A Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+2M sh	$10.00	+$20M	58,645,012
2021-02-10	NUVBNuvation Bio Inc.A Award	Director, PRESIDENT AND CEO, 10% Owner	AAward	+56.6M sh	—	—	56,645,012
2020-07-01	ARYA SCIENCES ACQUISITION CORP.Class B Ordinary SharesD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2020-06-10	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+5,101 sh	—	—	5,101
2020-06-10	NVCRNovoCure LtdA Award	Director	AAward	+2,541 sh	—	—	5,900
2020-05-26	ESTAESTABLISHMENT LABS HOLDINGS INC. · Stock Option (Right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-06-03	ESTAESTABLISHMENT LABS HOLDINGS INC. · Stock Option (Right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-05-22	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+6,340 sh	—	—	6,340
2019-05-22	NVCRNovoCure LtdA Award	Director	AAward	+3,359 sh	—	—	3,359
2018-05-31	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+45.1K sh	—	—	45,137
2017-12-29	Sio Gene Therapies Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Principal Executive Officer	MExercise/Conversion	+2M sh	—	—	2,000,000
2017-04-17	Sio Gene Therapies Inc.P Purchase	Director, Principal Executive Officer	PPurchase	+539K sh	$18.54	+$10M	539,375
2017-04-07	Sio Gene Therapies Inc.Employee Stock Option (Right to Buy)A Award	Director, Principal Executive Officer	AAward	+2M sh	—	—	2,000,000
2017-04-07	Sio Gene Therapies Inc.Employee Stock Option (Right to Buy)A Award	Director, Principal Executive Officer	AAward	+2M sh	—	—	2,000,000
2016-09-28	MEDIVATION, INC.Stock Appreciation RightsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−534K sh	—	—	0
2016-09-28	MEDIVATION, INC.Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−266K sh	—	—	0
2016-09-28	MEDIVATION, INC.Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−206K sh	—	—	0
2016-09-28	MEDIVATION, INC.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−94.3K sh	—	—	0
2016-09-28	MEDIVATION, INC.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−1.47M sh	—	—	0
2016-09-28	MEDIVATION, INC.Performance-Based Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−77.3K sh	—	—	0
2016-09-28	MEDIVATION, INC.Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−366K sh	—	—	0
2016-09-28	MEDIVATION, INC.Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−594K sh	—	—	0
2016-09-28	MEDIVATION, INC.Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−310K sh	—	—	0
2016-09-28	MEDIVATION, INC.Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−228K sh	—	—	0
2016-09-28	MEDIVATION, INC.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−145K sh	—	—	0

Recent filings

Accepted (ET)
Jun 54
Hung David0001310880-26-000006
SEC(opens sec.gov)
Jun 34
Hung David0001310880-26-000005
SEC(opens sec.gov)
Mar 34
Hung David0001310880-26-000003
SEC(opens sec.gov)
Jun 184
Hung David0001415889-25-017656
SEC(opens sec.gov)
Jun 64
Hung David0001562180-25-004556
SEC(opens sec.gov)
Jun 44
Hung David0001562180-25-004428
SEC(opens sec.gov)
Apr 84
Hung David0001415889-25-010446
SEC(opens sec.gov)
Mar 44
Hung David0001415889-25-006692
SEC(opens sec.gov)
Jun 64
Hung David0001562180-24-004768
SEC(opens sec.gov)
Mar 44
Hung David0001415889-24-006276
SEC(opens sec.gov)
Jun 94
Hung David0001562180-23-005015
SEC(opens sec.gov)
Mar 24
Hung David0001209191-23-014890
SEC(opens sec.gov)
Jun 104
Hung David0001645113-22-000054
SEC(opens sec.gov)
Mar 24
Hung David0001209191-22-014581
SEC(opens sec.gov)

Companies

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087